MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Dollar
Cash Flow
2025-09-30
2025-06-30
Net loss
-20,878,236 -7,087,167
Amortization
3,228 6,456
Prepaid
--10,680
Imputed interest
0 0
Share-based compensation
20,878,790 7,060,100
Accounts receivable
-35,000 50,000
Prepaid expense
6,675 -
Deferred share issuance cost
-5,000 -
Accounts payable and accrued liabilities
17,539 -13,468
Deferred share issuance cost
--5,000
Accrued interest
4,104 7,120
Net cash used in operating activities
64,430 -92,639
Net funds from acquisition of xirangsheng (shenzhen) health technology co., ltd
-1,458 -
Net cash provided by investing activities
1,458 -
Proceeds from loans
53,620 -
Repayment of loans
30,000 -
Proceeds from loans
-53,620
Proceed from related party
2,013 -
Proceeds from loan payable - related parties
29 23,016
Repayment of loan payable - related party
24,000 -
Net cash provided by financing activities
-51,958 76,636
Net change in cash and cash equivalents
13,930 -16,003
Cash and cash equivalents at beginning of period
16,103 -
Cash and cash equivalents at end of period
14,030 -
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

TRANSUITE.ORG INC. (TRSO)

TRANSUITE.ORG INC. (TRSO)